MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from issuance of
common stock and...
$7,161,504
Net cash provided by
financing activities
$5,202,981
Canceled cashflow
$1,958,523
Net increase in cash
and cash...
$425,089
Canceled cashflow
$4,777,892
Payment of issuance
costs related to...
$1,683,523
Repayment of notes
payable- related party
$275,000
Accounts payable- trade
$496,910
Stock-based compensation
$496,864
Shares issued in
exchange for services
$250,000
Amortization of debt issuance
costs and discounts
$53,722
Accrued interest
$14,190
Change in fair value of
derivative liabilities
$6,312
Net cash used in
operating activities
-$4,777,892
Canceled cashflow
$1,317,998
Net loss
-$5,167,569
Accrued expenses
-$453,445
Loss (gain) on
extinguishment of debt
$326,345
Prepaid expenses and
other current assets
$148,531
Back
Back
Cash Flow
source: myfinsight.com
ADAPTIN BIO, INC. (APTN)
ADAPTIN BIO, INC. (APTN)